News Image

Chembio’s CEO Letter to Stockholders

Provided By Globe Newswire

Last update: Apr 3, 2023

MEDFORD, N.Y., April 03, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA.

Read more at globenewswire.com
Follow ChartMill for more